Deborah Kilpatrick, chief commercial office for CardioDx, introduced the Corus CAD diagnostic and describes the reimbursement landscape for the technology.

Deborah Kilpatrick, chief commercial office for CardioDx, defines the four categories of evidence the company determined it would have to address to support widespread reimbursement and adoption of its test.

Deborah Kilpatrick, chief commercial office for CardioDx, outlines the company’s evidence strategy for Corus CAD including how the team prioritized requirements and sequenced its studies.

Deborah Kilpatrick, chief commercial office for CardioDx, shares her company’s experience establishing Medicare coverage and payment.

Deborah Kilpatrick, chief commercial office for CardioDx, outlines some of the challenges associated with establishing reimbursement with private payers in the U.S.

Deborah Kilpatrick, chief commercial office for CardioDx, summarizes key activities and the timeline associated with establishing reimbursement in the U.S. for Corus CAD.

Deborah Kilpatrick, chief commercial office for CardioDx, offers reimbursement advice to medtech innovators.